Frequently Asked Questions

Get answers to common questions about MOTs-C.

MOTs-C is a mitochondrial-derived peptide that regulates metabolic pathways, enhancing cellular energy and glucose utilization. It activates adaptive signaling like AMPK and improves mitochondrial efficiency, supporting endurance, faster recovery, and healthier metabolic responses to diet and exercise.

Ideal candidates include active individuals, athletes, or anyone experiencing reduced stamina, metabolic slowdown, or insulin resistance. Our medical team evaluates medical history, goals, and labs to determine safety and suitability before starting MOTs-C therapy for optimized results and personalized dosing.

MOTs-C is typically administered as a subcutaneous injection by our medical staff or trained patients following instruction. Treatment schedules vary — many start with a short loading phase then maintenance injections weekly or biweekly. Your provider will create a personalized protocol based on goals and labs.

Most people experience minimal effects, such as mild injection-site irritation or transient fatigue. Serious adverse events are rare, but MOTs-C may affect glucose and hormone-sensitive conditions. Pregnant or breastfeeding individuals and those with uncontrolled illnesses should avoid it until cleared by our medical team.

Some clients report increased energy and improved exercise capacity within days to a few weeks. Metabolic adaptations, weight changes, and enhanced endurance typically develop over several weeks to months. Results vary by lifestyle, dosing, and baseline metabolic health; consistent follow-up optimizes outcomes.

Always disclose all medications and supplements during consultation. MOTs-C can influence glucose metabolism and may alter responses to diabetes medications or hormone therapies. Our medical team reviews your regimen, adjusts dosing or monitors labs as needed to ensure safe, coordinated treatment.

fbq('track', 'Schedule')